Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease?

CR Freed - Proceedings of the national academy of …, 2002 - National Acad Sciences
Human embryonic stem (ES) cells en-tered the popular lexicon during the political debate of
summer 2001 and the decision by President George Bush to allow federal funding for …

Embryonic stem cells go dopaminergic

M Hynes, A Rosenthal - Neuron, 2000 - cell.com
Have a Lot of Potential ducing oligodendrocytes, the ES-derived glial precursor Stem cells
are a major component of the early embryo, cells differentiated to functional …

Neural stem cells for Parkinson's disease: to protect and repair

PR Sanberg - Proceedings of the National Academy of …, 2007 - National Acad Sciences
''Stem cells''and ''Parkinson's disease''are four words that signify some of the most important
translational research in neuroscience. The imagination of scientists has been captured by …

Stem cell‐based therapy for Parkinson's disease

AS Correia, SV Anisimov, JY Li, P Brundin - Annals of Medicine, 2005 - Taylor & Francis
Motor dysfunctions in Parkinson's disease are considered to be primarily due to the
degeneration of dopaminergic neurons in the substantia nigra pars compacta …

Dopamine cell replacement: Parkinson's disease.

DM Yurek, JR Sladek Jr - Annual review of neuroscience, 1990 - europepmc.org
Significant progress in neural transplantation has been observed over the last several
decades. As a neuroanatomical tool, neural transplantation studies are able to examine the …

Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease

CR Freed, RE Breeze, NL Rosenberg… - … England Journal of …, 1992 - Mass Medical Soc
Abstract Background and Methods. Patients with Parkinson's disease tend to have a
reduced response to levodopa after 5 to 20 years of therapy, with" on—off" fluctuations …

Current state of stem cell research for the treatment of Parkinson's disease

M Gerlach, H Braak, A Hartmann, WH Jost, P Odin… - Journal of …, 2002 - Springer
Current findings suggest that multipotent stem cells may be suitable for cell replacement
therapies in the treatment of neurodegenerative disorders. Embryonic stem (ES) cells are …

Transplantation of human fetal dopamine cells for Parkinson's disease: results at 1 year

CR Freed, RE Breeze, NL Rosenberg… - Archives of …, 1990 - jamanetwork.com
• In an effort to improve the clinical signs of Parkinson's disease, we have implanted
mesencephalic dopamine cells from a 7-week human embryo into the caudate and putamen …

Long‐term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno‐1) after transplantation

R Sánchez‐Pernaute, L Studer, D Ferrari, A Perrier… - Stem …, 2005 - academic.oup.com
Dopamine (DA) neurons can be derived from human and primate embryonic stem (ES) cells
in vitro. An ES cell–based replacement therapy for patients with Parkinson's disease …

Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma …

A Brederlau, AS Correia, SV Anisimov, M Elmi… - Stem …, 2006 - academic.oup.com
Human embryonic stem cells (hESCs) have been proposed as a source of dopamine (DA)
neurons for transplantation in Parkinson's disease (PD). We have investigated the effect of in …